Literature DB >> 2474684

Penetrating keratoplasty in the rat: a model for the study of immunosuppressive treatment of graft rejection.

C P Herbort1, M Matsubara, M Nishi, M Mochizuki.   

Abstract

The present study reports corneal allogeneic transplantation in a rat model. The technique used was full-thickness penetrating keratoplasty. Fisher rats were used as donors and Lewis rats were used as recipients. The rate of acute rejection obtained in this model with this combination of strains was 100%. It therefore seems to be a very useful model for the study of rejection and for the study of new immunosuppressive treatment. The effect of systemic cyclosporine (CsA) treatment on graft rejection was assessed using this model. Rejection was prevented by CsA as long as treatment was given but occurred in most grafts within 10 days of treatment cessation. Thus, tolerance could not be induced with CsA which, however, significantly reduced graft neovascularization.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474684

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  9 in total

1.  Corneal opacification following keratoplasty in the rat model.

Authors:  Ilse Claerhout
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

2.  Laser photocoagulation for corneal stromal vascularization.

Authors:  V S Nirankari
Journal:  Trans Am Ophthalmol Soc       Date:  1992

3.  Systemic ciclosporin A in high-risk keratoplasties.

Authors:  T Reinhard; R Sundmacher; P Heering
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

Review 4.  Systemic cyclosporine and corneal transplantation.

Authors:  Mohammed Ziaei; Fatemeh Ziaei; Bita Manzouri
Journal:  Int Ophthalmol       Date:  2016-02       Impact factor: 2.031

5.  Topical pimecrolimus does not prolong clear graft survival in a rat keratoplasty model.

Authors:  Florian Birnbaum; Johannes Schwartzkopff; Christoph Scholz; Thomas Reinhard
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-21       Impact factor: 3.117

6.  Effect of mycophenolate mofetil, cyclosporin A, and both in combination in a murine corneal graft rejection model.

Authors:  A Reis; T Reinhard; R Sundmacher; C Braunstein; E Godehardt
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

7.  FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations.

Authors:  K Mayer; F Birnbaum; T Reinhard; A Reis; S Braunstein; F Claas; R Sundmacher
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

8.  Hamster Greene melanoma in the rabbit eye: immunosuppressive treatment to improve this tumor model.

Authors:  I de Waard-Siebinga; J L van Delft; D de Wolff-Rouendaal; M Jager
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-11       Impact factor: 3.117

9.  Development and Effects of FTY720 Ophthalmic Solution on Corneal Allograft Survival.

Authors:  Zhaochuan Liu; Haotian Lin; Chulong Huang; Wan Chen; Wu Xiang; Yu Geng; Weirong Chen
Journal:  Sci Rep       Date:  2015-11-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.